Platform trial testing multiple drugs for Parkinson's disease
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests several experimental drugs at once to find new treatments for Parkinson's disease. If you have Parkinson's and take medication, you may be able to join and help speed up research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a Parkinson's diagnosis from a doctor.
- You must be at least 30 years old when diagnosed.
- You must have been on Parkinson's medication for at least 2 months.
- You cannot have other conditions that mimic Parkinson's, like essential tremor.
- You cannot have dementia or score low on a memory test.
- You cannot have had brain surgery or be on advanced therapies like deep brain stimulation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug, MTX325, in people with Parkinson's disease. The goal is to see if it is safe and how the body processes it, which may lead to new treatment options.
This trial tests a new oral medication for people with early-onset Parkinson's disease. It aims to see if the drug safely improves motor symptoms and quality of life compared to a placebo.
This trial tests a new drug called VT-5006 to see if it is safe for people with Parkinson's disease. It focuses on those who have stomach or bowel issues, like constipation.
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
This trial tests if the blood pressure drug terazosin can help slow down Parkinson's disease. It is for people recently diagnosed (within 3 years) who are not yet on many Parkinson's medications.
Hear when a new Parkinsons Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.